This inventor holds 5 USPTO granted patents and 14 published patent applications and 4 EPO patents. Top assignees: Case Western Reserve University, The University of Texas System, University of Kentucky Research Foundation. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 1,364 
5 out of 5,638 
2 out of 903 
Years Active: 2017-2025
Title: Monika Antczak: Innovator in Modulating Enzyme Activity
Introduction
Monika Antczak is a prominent inventor based in Ft. Worth, TX (US). She has made significant contributions to the field of biochemistry, particularly in the modulation of enzyme activities. With a total of five patents to her name, her work has implications for treating various diseases and disorders.
Latest Patents
Monika's latest patents focus on compositions and methods for modulating short-chain dehydrogenase activity. These patents include compounds and methods aimed at modulating 15-PGDH activity, which is crucial for regulating tissue prostaglandin levels. Her innovations are designed to treat diseases and conditions where modulation of 15-PGDH activity and prostaglandin levels is desired. The 15-PGDH inhibitors described in her patents represent a significant advancement in therapeutic options.
Career Highlights
Throughout her career, Monika has worked with esteemed institutions such as Case Western Reserve University and the University of Texas System. Her research has garnered attention for its potential to impact medical treatments and improve patient outcomes.
Collaborations
Monika has collaborated with notable colleagues, including Sanford D. Markowitz and Joseph Ready. These partnerships have enriched her research and contributed to the development of her innovative patents.
Conclusion
Monika Antczak stands out as a leading inventor in the field of enzyme modulation. Her work continues to pave the way for new therapeutic approaches, showcasing her dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile